2*FOLFOXIRI plus bevacizumab versus FOLFIRI plus...

Annals of Oncology 2015 / 10 Vol. 26; Iss. suppl 6

2*FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses:

Falcone, A., Cremolini, C., Antoniotti, C., Lonardi, S., Ronzoni, M., Zaniboni, A., Tonini, G., Salvatore, L., Masi, G., Mezi, S., Tomasello, G., Carlomagno, C., Allegrini, G., Chiara, S., D'Amico, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv335.02
Date:
October, 2015
File:
PDF, 46 KB
english, 2015
Conversion to is in progress
Conversion to is failed